SprinkleBit | Trinity Biotech Plc Sponsored ADR Class A (TRIB)

Community actions

Trinity Biotech Plc Sponsored ADR Class A news

Trinity Biotech to Announce Q3 2024 Financial Results
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
Trinity Biotech PLC (TRIB) Q2 2024 Earnings Call Highlights: Strong Point-of-Care Growth Amidst ...
Trinity Biotech Shares Surge on Positive Pre-Pivotal Clinical CGM Trial
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology
Trinity Biotech Acquires Preeclampsia Prediction Firm
Trinity Biotech's Stock Rises After Acquisition of Metabolomics
Trinity Biotech Acquires Preeclampsia Prediction Firm
Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market
Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Recent Motivations

Loretta Freeman
Bought

8 shares of
- 📈 The chart looks bullish
Mustafa Obeid
Bought

1085 shares of
- 📈 Grafen ser bra ut
Zaenab AL-dubaisy
Sold

2 shares of
- 💵 Frigör lite SprinkleBucks
Evelina Larsson
Sold

5 shares of
- 💵 Frigör lite SprinkleBucks
Evelina Larsson
Sold

10 shares of
- 📊 Jag tycker den är övervärderad just nu

05 July, 3:59 PM EST/EDT	Open$2.11	Ask$0.00 x 0	P/E0.00
TRIB	Day$2.09 - $2.11	Bid$0.00 x 0	Dividend (Yield %)$0.00 (0.00%)
Ronan O'Caoimh	52 Week$0.00 - $3.55	Volume345	US stocks data provided for free by IEX.
http://www.trinitybiotech.com	Mkt. Cap.$23.54M	EPS0.00

Trinity Biotech Plc Sponsored ADR Class A